Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
EDIT

Editas Medicine

$34.85

-3.14 (-8.27%)

17:03
05/18/18
05/18
17:03
05/18/18
17:03
Hot Stocks
Editas Medicine data shows subretinal EDIT-101 injection tolerated in primates »

Editas Medicine announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
SGMO

Sangamo

$14.55

-0.7 (-4.59%)

, NTLA

Intellia Therapeutics

$22.44

-0.31 (-1.36%)

07:38
05/11/18
05/11
07:38
05/11/18
07:38
Conference/Events
Jefferies to hold panel discussions »

Expert Panel: Trip to the…

SGMO

Sangamo

$14.55

-0.7 (-4.59%)

NTLA

Intellia Therapeutics

$22.44

-0.31 (-1.36%)

EDIT

Editas Medicine

$33.53

-0.93 (-2.70%)

CRSP

Crispr Therapeutics

$52.10

0.63 (1.22%)

LLY

Eli Lilly

$80.84

1.61 (2.03%)

TEVA

Teva

$19.25

-0.07 (-0.36%)

AMGN

Amgen

$170.75

1.11 (0.65%)

MRK

Merck

$58.05

0.09 (0.16%)

GSK

GlaxoSmithKline

$39.92

0.2298 (0.58%)

GILD

Gilead

$65.36

-0.33 (-0.50%)

NVS

Novartis

$76.94

-0.14 (-0.18%)

ONCE

Spark Therapeutics

$76.11

0.08 (0.11%)

BIIB

Biogen

$273.98

0.13 (0.05%)

ICPT

Intercept

$71.21

-0.78 (-1.08%)

REGN

Regeneron

$288.92

4.5 (1.58%)

PCRX

Pacira

$34.20

-0.2 (-0.58%)

WVE

Wave Life Sciences

$40.60

-2.1 (-4.92%)

ALNY

Alnylam

$98.20

1.28 (1.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    May

  • 15

    May

  • 15

    May

  • 16

    May

  • 17

    May

  • 18

    May

  • 20

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 28

    May

  • 30

    May

  • 05

    Jun

  • 07

    Jun

  • 16

    Jun

  • 11

    Aug

  • 20

    Oct

  • 23

    Oct

EDIT

Editas Medicine

$33.50

1.88 (5.95%)

, CELG

Celgene

$88.19

2.81 (3.29%)

09:51
05/04/18
05/04
09:51
05/04/18
09:51
Hot Stocks
Editas jumps after expanding oncology collaboration with Celgene »

Editas Medicine (EDIT) in…

EDIT

Editas Medicine

$33.50

1.88 (5.95%)

CELG

Celgene

$88.19

2.81 (3.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 08

    May

  • 18

    May

  • 30

    May

EDIT

Editas Medicine

$31.62

-1.05 (-3.21%)

16:15
05/03/18
05/03
16:15
05/03/18
16:15
Earnings
Editas Medicine reports Q1 EPS (67c), consensus (82c) »

Reports Q1 revenue $3.9M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

CRSP

Crispr Therapeutics

$49.01

1.21 (2.53%)

, EDIT

Editas Medicine

$32.60

0.87 (2.74%)

15:16
04/26/18
04/26
15:16
04/26/18
15:16
Hot Stocks
CRISPR technology to be featured on this week's 60 Minutes »

In a preview for the…

CRSP

Crispr Therapeutics

$49.01

1.21 (2.53%)

EDIT

Editas Medicine

$32.60

0.87 (2.74%)

NTLA

Intellia Therapeutics

$20.20

-0.27 (-1.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

EDIT

Editas Medicine

$32.65

-1.8 (-5.23%)

, CRSP

Crispr Therapeutics

$49.21

-4.84 (-8.95%)

10:20
04/23/18
04/23
10:20
04/23/18
10:20
Hot Stocks
CRISPR stocks slide after Merck KGaA gets patent in China »

Merck KGaA (MKGAY) of…

EDIT

Editas Medicine

$32.65

-1.8 (-5.23%)

CRSP

Crispr Therapeutics

$49.21

-4.84 (-8.95%)

NTLA

Intellia Therapeutics

$21.47

-0.25 (-1.15%)

MKGAY

Merck KGaA

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

Over a month ago
EDIT

Editas Medicine

$41.51

0.09 (0.22%)

14:15
03/15/18
03/15
14:15
03/15/18
14:15
Options
Editas Medicine put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EDIT

Editas Medicine

$41.51

0.09 (0.22%)

, NTLA

Intellia Therapeutics

$28.81

-4.41 (-13.28%)

13:28
03/15/18
03/15
13:28
03/15/18
13:28
Hot Stocks
CRISPR stocks plunge after Solid clinical hold, Arbor breakthrough »

Shares of companies…

EDIT

Editas Medicine

$41.51

0.09 (0.22%)

NTLA

Intellia Therapeutics

$28.81

-4.41 (-13.28%)

CRSP

Crispr Therapeutics

$58.17

1.66 (2.94%)

SLDB

Solid Biosciences

$26.31

-0.13 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

EDIT

Editas Medicine

$41.77

-2.31 (-5.24%)

16:55
03/12/18
03/12
16:55
03/12/18
16:55
Syndicate
Breaking Syndicate news story on Editas Medicine »

Editas Medicine files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EDIT

Editas Medicine

$41.77

-2.31 (-5.24%)

16:53
03/12/18
03/12
16:53
03/12/18
16:53
Syndicate
Breaking Syndicate news story on Editas Medicine »

Editas Medicine files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.